SUBSCRIBERS
Stada dives as 5.3b euro bid fails to lure enough shareholders
Published Tue, Jun 27, 2017 · 09:50 PM
Paris
STADA Arzneimittel AG shares dropped the most in a year after the German generic-drug maker's planned 5.3 billion-euro (S$8.3 billion) sale to two buyout firms fell apart as a small group of investors held out for a better deal.
Only 65.5 per cent of the shares were tendered in Bain Capital and Cinven's offer by the deadline on Thursday, Bad Vilbel, Germany-based Stada …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Banking & Finance
Japan brokerage Daiwa’s Q4 profit more than doubles as markets recover
Barclays Q1 profit falls 12% as mortgage competition, deals drought hit
Deutsche Bank Q1 profit jumps 10% as investment bank outperforms
Latest Singapore 6-month T-bill offering cut-off yield of 3.74% as applications dip
Morgan Stanley Asia private equity unit to reorganise as CEO retires
US seeks 36 months’ jail for Binance founder Zhao